Literature DB >> 12938676

Retrospective study of the safety of caspofungin in immunocompromised pediatric patients.

Jeremy A Franklin1, John McCormick, Patricia M Flynn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12938676     DOI： 10.1097/01.inf.0000078164.80233.14

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.

Authors:  Thomas J Walsh; Peter C Adamson; Nita L Seibel; Patricia M Flynn; Michael N Neely; Cindy Schwartz; Aziza Shad; Sheldon L Kaplan; Maureen M Roden; Julie A Stone; Alisha Miller; Susan K Bradshaw; Susan X Li; Carole A Sable; Nicholas A Kartsonis
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  A review of clinical experience with newer antifungals in children.

Authors:  Renee M Fallon; Jennifer E Girotto
Journal:  J Pediatr Pharmacol Ther       Date:  2008-07

3.  Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient.

Authors:  Ashley Munchel; Allen Chen; Heather Symons
Journal:  Clin Pediatr Emerg Med       Date:  2011-09

Review 4.  Advances in the treatment of invasive neonatal candidiasis.

Authors:  Lorena Botero-Calderon; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  Expert Opin Pharmacother       Date:  2015-04-05       Impact factor: 4.103

Review 5.  Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome.

Authors:  Joanna Filioti; Kleomenis Spiroglou; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

6.  Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Authors:  Michaela Döring; Ulrike Hartmann; Annika Erbacher; Peter Lang; Rupert Handgretinger; Ingo Müller
Journal:  BMC Infect Dis       Date:  2012-07-02       Impact factor: 3.090

Review 7.  Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.

Authors:  Julie Autmizguine; Jeffrey T Guptill; Michael Cohen-Wolkowiez; Daniel K Benjamin; Edmund V Capparelli
Journal:  Drugs       Date:  2014-06       Impact factor: 11.431

8.  Comparison of echinocandin antifungals.

Authors:  Gregory Eschenauer; Daryl D Depestel; Peggy L Carver
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.